(Q34482021)

2 August 2017

1 reference

title

Dehydroepiandrosterone for the treatment of systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

2 August 2017

0 references

author

Ronald van Vollenhoven

series ordinal

1

object named as

Ronald F van Vollenhoven

0 references

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Expert Opinion on Pharmacotherapy

2 August 2017

1 reference

2 August 2017

3

1 reference

2 August 2017

1

1 reference

2 August 2017

23-31

1 reference

Physiological importance of dehydroepiandrosterone

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.1.23

Low plasma androgens in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.1.23

Androgenic hormones modulate autoantibody responses and improve survival in murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.1.23

Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.1.23

Dehydroepiandrosterone (DHEA) treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.1.23

Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.1.23

Alterations of estrogen metabolism in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.1.23

Increased oxidation of testosterone in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.1.23

21 January 2018

Identifiers

DOI

10.1517/14656566.3.1.23

1 reference

2 August 2017

1 reference

PubMed ID

11772330